Clinical Trial Update: Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients [Phase 1]

View source ↗

Summary

Phase 1a/1b study of TRB-061 in healthy participants and adults with moderate-to-severe atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TRB-061

Snippet

Sponsor: TRex Bio, Inc. | Conditions: Moderate-to-severe Atopic Dermatitis | Phase 1 | Status: RECRUITING